Case study · Telehealth

The marketing hit cloud nine. The business still didn't grow.

They'd already paid for one launch that produced a healthy click-through rate and no patients. The second engine worked. The hard part was what it revealed.

Chronic-condition telehealth company an eighteen-month engagement The rebuilt engine delivered about 870 leads at under $17 each at roughly half the planned spend, later hundreds of qualified leads a month at best-in-class cost, and one honest diagnosis: the constraint wasn't marketing anymore. It was sales.

What the company believed walking in

A chronic-condition telehealth company came in carrying a failed launch. A prior firm had run the spend, reported a healthy click-through rate, and produced no patients. The number looked fine, the business got nothing, and nobody could explain the gap between the two.

So the team believed what most teams believe after that experience: the marketing was bad, and the fix is better marketing. Sharper ads, a sharper funnel, a firm that actually knows what it’s doing. It’s a reasonable belief. It’s also only half the story, and the half it misses is the expensive half.

What we saw

The click-through rate wasn’t a lie, but it was the wrong instrument. A click-through rate tells you people liked the ad, and it says nothing about whether any of them became a patient. Nothing in the old setup could say, because there was no attribution underneath it. Money went in, a flattering number came out, and the machine in between was unmeasured.

The ownership was just as loose. Accounts and assets sat wherever the prior work had left them, which is how a company ends up renting its own marketing.

What we decided, and what we chose not to do

We refused to start with spend. That refusal is the whole decision, and it’s the step the previous launch skipped.

Attribution got built first, so every dollar could be traced to a lead and every lead to what happened after it. Ownership got cleaned up on a simple rule: the owner owns every account, and everyone else, including us, is an admin. And the launch itself was reframed as an instrument, not a fireworks show. We said it up front: the first month is data collection. You’re not buying patients in month one, you’re buying the truth about what a patient costs.

What we built

A funnel built to convert and to be measured: roughly a $60,000 build, with a further $30,000 addition after the first version validated. That order matters, because the addition was earned by data, not sold on faith. The funnel and the site remain in use years later, with minor adjustments.

Then the engine got tuned on what the instruments showed.

  • Channel intent. Of 22 closed deals in a four-month window, only 2 had come from the social channel. The budget shifted roughly 75% to search the next day. Not next quarter, the next day, because acting that fast is what attribution is for.
  • A clinician-recorded video replaced the stock footage on the funnel, and the scheduled-meeting rate went from about 13% to about 20%.
  • Show-rate work. Reminder and scheduling fixes took the show rate from about 18% to 30-40%.

What changed

The lead engine became genuinely excellent. About 870 leads came in at under $17 each, at roughly half the planned spend, and at maturity the machine produced hundreds of qualified leads a month at best-in-class cost. By every lead-side measure, this was cloud-nine performance. These figures are attested by us from our own engagement records, not independently audited, and they’re not a promise of what your business will do.

And the business still wasn’t growing.

That gap is the finding that matters, so we ran the honest workup instead of taking a bow. In one 30-day window, roughly one deal closed out of about forty-two qualified leads. On the sales calls, the closer was doing most of the talking, and the price surfaced late, buried at the end. The proof side told the same story: about two testimonials standing against roughly a hundred closed deals, while a category competitor carried about a thousand reviews. The product wasn’t the gap. The process was, because nobody’s job was to ask.

So we said it plainly. By every lead-side measure you’re in cloud-nine territory. You don’t need more marketing. You need a sales function.

How it ended

The engagement closed in a governed exit. The runway called for a different structure, so the diagnosis was delivered in plain words and everything was handed over working. The funnel, the site, the accounts, the data: all of it stayed in the client’s hands and kept running, because we operate on a principle of our own. It’s not yours if you can’t keep it.

The lesson

A perfect lead engine can’t save a broken step after the lead. Marketing fills the top of the machine, and if the step after the lead is broken, better marketing just delivers more people to the same broken step, faster and at greater cost.

The two problems even feel identical from the owner’s chair, because both of them read as “we’re not growing.” Only honest measurement can tell them apart. That’s the real reason to build attribution before you build spend: not to decorate a dashboard, but so that when growth stalls, you know which half of the machine to fix.

An honest partner tells you which one you have, even when the answer is that their part of the machine is done and the next constraint belongs to you. Before you buy more leads, ask what happens to the ones you already get. The answer is usually cheaper than the ads.

Want this level of clarity on your own numbers?

Start with a conversation. If it is a fit, the Second Opinion shows you the truth on your real numbers, with the written diagnosis about a week after the final working session.

Start with a conversation

Figures are attested by the agency from its own engagement records, not independently audited, and are not a promise of similar results. Every business is different.